Intrahepatic Cholestasis of Pregnancy and Associated Adverse Maternal and Fetal Outcomes: A Retrospective Case-Control Study
Objective. Intrahepatic cholestasis of pregnancy (ICP) is a common pregnancy-related liver disease and is associated with an increased risk of adverse neonatal outcomes. Ursodeoxycholic acid (UDCA) is the most effective treatment. This study was aimed at investigating the adverse outcomes of ICP and...
Saved in:
Main Authors: | Mingjuan Luo, Mengyang Tang, Feng Jiang, Yizhen Jia, Robert Kien Howe Chin, Wei Liang, Hu Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2021/6641023 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Bile Acid on Fetal Lung in Rat Model of Intrahepatic Cholestasis of Pregnancy
by: Ling Yu, et al.
Published: (2014-01-01) -
Clinical presentation, diagnosis and treatment of intrahepatic cholestasis of pregnancy
by: Yu. B. Uspenskaya, et al.
Published: (2018-08-01) -
Asymptomatic intrahepatic cholestasis of pregnancy: features of course, diagnostics and treatment
by: Yu. B. Uspenskaya, et al.
Published: (2018-08-01) -
Association between ABCB4 variants and intrahepatic cholestasis of pregnancy
by: Dekun Zhang, et al.
Published: (2025-01-01) -
Intrahepatic Cholestasis of Pregnancy Leading to Severe Vitamin K Deficiency and Coagulopathy
by: Maria Maldonado, et al.
Published: (2017-01-01)